- Home
- OLP vs EYPT Comparison
OLP vs EYPT Comparison
Compare OLP & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- EYPT
- Stock Information
- Founded
- OLP 1982
- EYPT 1987
- Country
- OLP United States
- EYPT United States
- Employees
- OLP N/A
- EYPT N/A
- Industry
- OLP Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- OLP Real Estate
- EYPT Industrials
- Exchange
- OLP Nasdaq
- EYPT Nasdaq
- Market Cap
- OLP 483.3M
- EYPT 741.0M
- IPO Year
- OLP N/A
- EYPT 2005
- Fundamental
- Price
- OLP $23.15
- EYPT $13.76
- Analyst Decision
- OLP
- EYPT Strong Buy
- Analyst Count
- OLP 0
- EYPT 6
- Target Price
- OLP N/A
- EYPT $25.83
- AVG Volume (30 Days)
- OLP 59.0K
- EYPT 823.7K
- Earning Date
- OLP 11-04-2025
- EYPT 11-06-2025
- Dividend Yield
- OLP 7.80%
- EYPT N/A
- EPS Growth
- OLP N/A
- EYPT N/A
- EPS
- OLP 1.29
- EYPT N/A
- Revenue
- OLP $94,839,000.00
- EYPT $51,898,000.00
- Revenue This Year
- OLP $11.08
- EYPT N/A
- Revenue Next Year
- OLP $4.64
- EYPT N/A
- P/E Ratio
- OLP $17.91
- EYPT N/A
- Revenue Growth
- OLP 7.07
- EYPT 2.99
- 52 Week Low
- OLP $21.94
- EYPT $3.91
- 52 Week High
- OLP $30.45
- EYPT $14.42
- Technical
- Relative Strength Index (RSI)
- OLP 50.39
- EYPT 66.97
- Support Level
- OLP $22.75
- EYPT $12.88
- Resistance Level
- OLP $23.68
- EYPT $14.15
- Average True Range (ATR)
- OLP 0.40
- EYPT 0.76
- MACD
- OLP -0.03
- EYPT 0.02
- Stochastic Oscillator
- OLP 41.58
- EYPT 79.11
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.